Cargando…

Equine Polyclonal Antibodies Prevent Acute Chikungunya Virus Infection in Mice

Chikungunya virus (CHIKV) is a mosquito-transmitted pathogen that causes chikungunya disease (CHIK); the disease is characterized by fever, muscle ache, rash, and arthralgia. This arthralgia can be debilitating and long-lasting, seriously impacting quality of life for years. Currently, there is no s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barker, Douglas, Han, Xiaobing, Wang, Eryu, Dagley, Ashley, Anderson, Deborah M., Jha, Aruni, Weaver, Scott C., Julander, Justin, Nykiforuk, Cory, Kodihalli, Shantha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384969/ https://www.ncbi.nlm.nih.gov/pubmed/37515166 http://dx.doi.org/10.3390/v15071479

Ejemplares similares

Pharmacokinetic and Pharmacodynamic Effects of Polyclonal Antibodies against SARS-CoV2 in Mice
por: Jha, Aruni, et al.
Publicado: (2022)

Therapeutic efficacy of equine botulism heptavalent antitoxin against all seven botulinum neurotoxins in symptomatic guinea pigs
por: Barker, Douglas, et al.
Publicado: (2019)

Efficacy of equine botulism antitoxin in botulism poisoning in a guinea pig model
por: Emanuel, Andrew, et al.
Publicado: (2019)

Human Polyclonal Antibodies Prevent Lethal Zika Virus Infection in Mice
por: Branche, Emilie, et al.
Publicado: (2019)

Efficacy of COVID-HIGIV in animal models of SARS-CoV-2 infection
por: Jha, Aruni, et al.
Publicado: (2022)

Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques
por: Kodihalli, Shantha, et al.
Publicado: (2017)

The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus Disease
por: Pinto, Amelia K., et al.
Publicado: (2021)

Exposure‐Response Modeling and Simulation to Support Human Dosing of Botulism Antitoxin Heptavalent Product
por: Beliveau, Martin, et al.
Publicado: (2022)

Chikungunya Virus 3′ Untranslated Region: Adaptation to Mosquitoes and a Population Bottleneck as Major Evolutionary Forces
por: Chen, Rubing, et al.
Publicado: (2013)

Venezuelan Equine Encephalitis Virus Transmission and Effect on Pathogenesis
por: Smith, Darci R., et al.
Publicado: (2006)

Antibodies for Venezuelan Equine Encephalitis Virus Protect Embryoid Bodies from Chikungunya Virus
por: Schultz, Emily M., et al.
Publicado: (2020)

Potent Neutralizing Activity of Polyclonal Equine Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern
por: Luczkowiak, Joanna, et al.
Publicado: (2022)

Postepizootic Persistence of Venezuelan Equine Encephalitis Virus, Venezuela
por: Navarro, Juan-Carlos, et al.
Publicado: (2005)

Correction to: Potent Neutralizing Activity of Polyclonal Equine Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern
Publicado: (2022)

Structural constraints link differences in neutralization potency of human anti-Eastern equine encephalitis virus monoclonal antibodies
por: Williamson, Lauren E., et al.
Publicado: (2023)

Production of Erythropoietin-Specific Polyclonal Antibodies
por: Maboudi, Kourosh, et al.
Publicado: (2017)

Passive Monoclonal and Polyclonal Antibody Therapies
por: Pelletier, J. Peter R., et al.
Publicado: (2020)

Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates
por: Rossi, Shannan L, et al.
Publicado: (2019)

Human Polyclonal Antibodies Produced from Transchromosomal Bovine Provides Prophylactic and Therapeutic Protections Against Zika Virus Infection in STAT2 KO Syrian Hamsters
por: Siddharthan, Venkatraman, et al.
Publicado: (2019)

Back to the future: recombinant polyclonal antibody therapeutics
por: Wang, Xian-zhe, et al.
Publicado: (2013)

Monoclonal and Polyclonal Antibodies Specific to Human Fibromodulin
por: Farahi, Lia, et al.
Publicado: (2019)

Conjugation of R-Phycoerythrin to a Polyclonal Antibody and F (ab')2 Fragment of a Polyclonal Antibody by Two Different Methods
por: Mahmoudian, Jafar, et al.
Publicado: (2010)

Non-clinical safety assessment and in vivo biodistribution of CoviFab, an RBD-specific F(ab′)2 fragment derived from equine polyclonal antibodies
por: Salinas, Facundo, et al.
Publicado: (2022)

Polyclonal F(ab’)(2) fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potency
por: Cunha, Luis Eduardo R., et al.
Publicado: (2021)

Single-Batch Production of Recombinant Human Polyclonal Antibodies
por: Nielsen, Lars S., et al.
Publicado: (2010)

Characterization of a novel polyclonal anti-hypusine antibody
por: Nishiki, Yurika, et al.
Publicado: (2013)

Polyclonal antibodies for the detection of Trypanosoma cruzi circulating antigens
por: Málaga-Machaca, Edith S., et al.
Publicado: (2017)

Development of Polyclonal Antibody against Clenbuterol for Immunoassay Application
por: Talib, Nurul Ain A., et al.
Publicado: (2018)

Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology
por: Berry, Jody D., et al.
Publicado: (2011)

A tool for evaluating heterogeneity in avidity of polyclonal antibodies
por: Li, Kan, et al.
Publicado: (2023)

Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies
por: Struble, Evi B., et al.
Publicado: (2023)

Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases
por: Tharmalingam, Tharmala, et al.
Publicado: (2021)

Novel Chikungunya Vaccine Candidate with an IRES-Based Attenuation and Host Range Alteration Mechanism
por: Plante, Kenneth, et al.
Publicado: (2011)

Preparation and Characterization of a Polyclonal Antibody against Brominated Protein
por: Kambayashi, Yasuhiro, et al.
Publicado: (2009)

Non-specific polyclonal antibody response induced by Mycoplasma pneumoniae.
por: Biberfeld, G., et al.
Publicado: (1983)

Systematic profiling of polyclonal HIV antibodies and prediction of effector functions
por: Brown, E
Publicado: (2012)

Polyclonal Antibody Production for Membrane Proteins via Genetic Immunization
por: Hansen, Debra T., et al.
Publicado: (2016)

Production and application of polyclonal and monoclonal antibodies against Spiroplasma eriocheiris
por: Zhang, Ying, et al.
Publicado: (2015)

Requirement of a Blocking Step in Affinity Purification of Polyclonal Antibodies
por: Hamzehlou, Sepideh, et al.
Publicado: (2015)

Shaping Polyclonal Responses via Antigen-Mediated Antibody Interference
por: Yan, Le, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mdt38a6d5n5lolndvtjb2n4qi0